These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31709791)

  • 1. Structural Insight into the Mechanism of Inhibitor Resistance in CTX-M-199, a CTX-M-64 Variant Carrying the S
    Cheng Q; Xu C; Chai J; Zhang R; Wai Chi Chan E; Chen S
    ACS Infect Dis; 2020 Apr; 6(4):577-587. PubMed ID: 31709791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Conformations of Acylation Adducts of Inhibitors of β-Lactamase from Mycobacterium tuberculosis.
    Tassoni R; Blok A; Pannu NS; Ubbink M
    Biochemistry; 2019 Feb; 58(7):997-1009. PubMed ID: 30632739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the inhibitor-resistant M69V substitution on the structures and populations of trans-enamine beta-lactamase intermediates.
    Totir MA; Padayatti PS; Helfand MS; Carey MP; Bonomo RA; Carey PR; van den Akker F
    Biochemistry; 2006 Oct; 45(39):11895-904. PubMed ID: 17002290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High resolution crystal structures of the trans-enamine intermediates formed by sulbactam and clavulanic acid and E166A SHV-1 {beta}-lactamase.
    Padayatti PS; Helfand MS; Totir MA; Carey MP; Carey PR; Bonomo RA; van den Akker F
    J Biol Chem; 2005 Oct; 280(41):34900-7. PubMed ID: 16055923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penicillanic Acid Sulfones Inactivate the Extended-Spectrum β-Lactamase CTX-M-15 through Formation of a Serine-Lysine Cross-Link: an Alternative Mechanism of β-Lactamase Inhibition.
    Hinchliffe P; Tooke CL; Bethel CR; Wang B; Arthur C; Heesom KJ; Shapiro S; Schlatzer DM; Papp-Wallace KM; Bonomo RA; Spencer J
    mBio; 2022 Jun; 13(3):e0179321. PubMed ID: 35612361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raman crystallographic studies of the intermediates formed by Ser130Gly SHV, a beta-lactamase that confers resistance to clinical inhibitors.
    Helfand MS; Taracila MA; Totir MA; Bonomo RA; Buynak JD; van den Akker F; Carey PR
    Biochemistry; 2007 Jul; 46(29):8689-99. PubMed ID: 17595114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the molecular determinants of substrate and inhibitor specificities in the Carbapenemase KPC-2: exploring the roles of Arg220 and Glu276.
    Papp-Wallace KM; Taracila MA; Smith KM; Xu Y; Bonomo RA
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4428-38. PubMed ID: 22687511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical characterization of CTX-M-15 from Enterobacter cloacae and designing a novel non-β-lactam-β-lactamase inhibitor.
    Faheem M; Rehman MT; Danishuddin M; Khan AU
    PLoS One; 2013; 8(2):e56926. PubMed ID: 23437273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residues Distal to the Active Site Contribute to Enhanced Catalytic Activity of Variant and Hybrid β-Lactamases Derived from CTX-M-14 and CTX-M-15.
    He D; Chiou J; Zeng Z; Liu L; Chen X; Zeng L; Chan EW; Liu JH; Chen S
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5976-83. PubMed ID: 26169409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Mind the Gap": Raman Evidence for Rapid Inactivation of CTX-M-9 β-Lactamase Using Mechanism-Based Inhibitors that Bridge the Active Site.
    Heidari-Torkabadi H; Bethel CR; Ding Z; Pusztai-Carey M; Bonnet R; Bonomo RA; Carey PR
    J Am Chem Soc; 2015 Oct; 137(40):12760-3. PubMed ID: 26421661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the inhibition of CTX-M-9 by beta-lactamase inhibitors and carbapenems.
    Bethel CR; Taracila M; Shyr T; Thomson JM; Distler AM; Hujer KM; Hujer AM; Endimiani A; Papp-Wallace K; Bonnet R; Bonomo RA
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3465-75. PubMed ID: 21555770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A drug-resistant β-lactamase variant changes the conformation of its active-site proton shuttle to alter substrate specificity and inhibitor potency.
    Soeung V; Lu S; Hu L; Judge A; Sankaran B; Prasad BVV; Palzkill T
    J Biol Chem; 2020 Dec; 295(52):18239-18255. PubMed ID: 33109613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTX-M-190, a Novel β-Lactamase Resistant to Tazobactam and Sulbactam, Identified in an Escherichia coli Clinical Isolate.
    Shen Z; Ding B; Bi Y; Wu S; Xu S; Xu X; Guo Q; Wang M
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane-Tazobactam in Pseudomonas aeruginosa.
    Barnes MD; Taracila MA; Rutter JD; Bethel CR; Galdadas I; Hujer AM; Caselli E; Prati F; Dekker JP; Papp-Wallace KM; Haider S; Bonomo RA
    mBio; 2018 Dec; 9(6):. PubMed ID: 30538183
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase.
    Papp-Wallace KM; Bethel CR; Distler AM; Kasuboski C; Taracila M; Bonomo RA
    Antimicrob Agents Chemother; 2010 Feb; 54(2):890-7. PubMed ID: 20008772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of the class A extended-spectrum β-lactamase CTX-M-96 in complex with relebactam at 1.03 Angstrom resolution.
    Ghiglione B; Rodríguez MM; Penzotti P; Bethel CR; Gutkind G; Bonomo RA; Klinke S; Power P
    Antimicrob Agents Chemother; 2024 Aug; 68(8):e0172123. PubMed ID: 38990013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-function studies of arginine at position 276 in CTX-M beta-lactamases.
    Pérez-Llarena FJ; Cartelle M; Mallo S; Beceiro A; Pérez A; Villanueva R; Romero A; Bonnet R; Bou G
    J Antimicrob Chemother; 2008 Apr; 61(4):792-7. PubMed ID: 18281307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different intermediate populations formed by tazobactam, sulbactam, and clavulanate reacting with SHV-1 beta-lactamases: Raman crystallographic evidence.
    Kalp M; Totir MA; Buynak JD; Carey PR
    J Am Chem Soc; 2009 Feb; 131(6):2338-47. PubMed ID: 19161282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure, function, and inhibition along the reaction coordinate of CTX-M beta-lactamases.
    Chen Y; Shoichet B; Bonnet R
    J Am Chem Soc; 2005 Apr; 127(15):5423-34. PubMed ID: 15826180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substitution of Met-69 by Ala or Gly in TEM-1 beta-lactamase confer an increased susceptibility to clavulanic acid and other inhibitors.
    Madec S; Blin C; Krishnamoorthy R; Picard B; Chaibi el B; Fouchereau-Péron M; Labia R
    FEMS Microbiol Lett; 2002 May; 211(1):13-6. PubMed ID: 12052544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.